Stephen Davis

Insider Reports History

Entity
Individual
Location
Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Davis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ACADIA PHARMACEUTICALS INC CEO, Director Common Stock 187K $2.85M $15.28 Aug 19, 2024 Direct
ACADIA PHARMACEUTICALS INC CEO, Director Restricted Stock Units 67.2K $1.2M $17.87 May 1, 2024 Direct
HERON THERAPEUTICS, INC. /DE/ Director Stock Option (Right to Buy) 77.2K $137K $1.78 Dec 16, 2022 Direct
HERON THERAPEUTICS, INC. /DE/ Director Common Stock 52K $112K $2.15 Dec 16, 2022 Direct
ACADIA PHARMACEUTICALS INC CEO, Director Stock Option (Right to Buy) 286K Mar 25, 2024 Direct
BELLICUM PHARMACEUTICALS, INC Director Common Stock 137K Jan 3, 2023 Direct

Insider Reports Filed by Stephen Davis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACAD ACADIA PHARMACEUTICALS INC Aug 16, 2024 3 -$485K 4 Aug 20, 2024 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC May 1, 2024 3 -$194K 4 May 3, 2024 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Apr 5, 2024 6 -$475K 4 Apr 9, 2024 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Mar 25, 2024 3 -$317K 4 Mar 27, 2024 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Feb 23, 2024 3 -$138K 4 Feb 27, 2024 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Jan 6, 2024 3 -$112K 4 Jan 9, 2024 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Oct 5, 2023 3 -$1.13M 4 Oct 6, 2023 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Jul 14, 2023 3 -$927K 4 Jul 18, 2023 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Jul 11, 2023 2 -$1.79M 4 Jul 13, 2023 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC May 1, 2023 2 $0 4 May 3, 2023 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Apr 29, 2023 3 -$165K 4 May 2, 2023 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Apr 5, 2023 3 -$156K 4 Apr 7, 2023 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Feb 23, 2023 3 -$72.3K 4 Feb 27, 2023 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Jan 6, 2023 3 -$66.9K 4 Jan 10, 2023 CEO, Director
BLCM BELLICUM PHARMACEUTICALS, INC Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Dec 16, 2022 2 $0 4 Dec 20, 2022 Director
ACAD ACADIA PHARMACEUTICALS INC Oct 15, 2022 3 -$44.3K 4 Oct 18, 2022 CEO, Director
BLCM BELLICUM PHARMACEUTICALS, INC Sep 1, 2022 1 $0 4 Sep 2, 2022 Director
BLCM BELLICUM PHARMACEUTICALS, INC Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
ACAD ACADIA PHARMACEUTICALS INC Apr 29, 2022 3 -$99.7K 4 May 3, 2022 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Apr 5, 2022 3 $0 4 Apr 7, 2022 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Feb 23, 2022 3 -$93.5K 4 Feb 25, 2022 CEO, Director
ACAD ACADIA PHARMACEUTICALS INC Jan 6, 2022 3 -$85.7K 4 Jan 10, 2022 CEO, Director
BLCM BELLICUM PHARMACEUTICALS, INC Jan 4, 2022 2 $0 4 Jan 6, 2022 Director
HRTX HERON THERAPEUTICS, INC. /DE/ Dec 22, 2021 2 $0 4 Dec 23, 2021 Director
ACAD ACADIA PHARMACEUTICALS INC Oct 15, 2021 3 -$51.6K 4 Oct 19, 2021 CEO, Director
BLCM BELLICUM PHARMACEUTICALS, INC Jun 15, 2021 1 $0 4 Jul 7, 2021 Director